Previous 10 | Next 10 |
2023-09-22 15:00:17 ET More on the markets No Signs Of A Major Top Yet, Staying Long BofA strategists have changed their view of the S&P 500 target, up 4%. Quant stock news sentiment measure keeps improving - BofA Amazon, Disney, Boeing boosted in Wells F...
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, will livestream its inaugural Capital Markets Day on September 27, 2023 from 11:00 a.m. ET to approximate...
2023-09-15 05:21:46 ET Summary Stevanato Group is a global provider of drug containment with a CAPEX growth plan to support growth and reach new geographical diversification. Balance sheet flexibility thanks to margin expansions. Strong secular tailwinds in biologics support t...
2023-07-30 11:23:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Discovery Fund® (the Fund) appreciated 3.58% (Institutional Shares) in the ...
2023-07-28 14:32:07 ET Stevanato Group S.p.A. (STVN) Q2 2023 Earnings Conference Call July 28, 2023 8:30 AM ET Company Participants Lisa Miles - Senior Vice President, Investor Relations Franco Stevanato - Executive Chairman Franco Moro - Chief Executive Officer ...
2023-07-28 06:46:17 ET Stevanato Group press release ( NYSE: STVN ): Q2 Non-GAAP EPS of €0.14. Revenue of €255.3M (+9.0% Y/Y). For further details see: Stevanato Group Non-GAAP EPS of €0.14, revenue of €255.3M
- Reiterates Full Year 2023 Revenue and Adjusted Diluted Earnings per Share Guidance; Increases Adjusted EBITDA Guidance - Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, an...
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the second quarter of 2023 on Friday, July 28, 2...
2023-06-14 04:21:48 ET Summary Stevenato Group is a Pharmaceutical Manufacturing leader, generating 15% net income margins annually. The company has developed a global customer base over the course of its 70-year operating history and continues to add new clients with each passing...
The Company offers the platform as a readily customizable pre-filled and pre-loaded on-body solution for drug delivery. Device development is making significant progress, with samples expected to be available in 2023 Stevanato Group S.p.A . (NYSE: STVN), a leading global provider of...
News, Short Squeeze, Breakout and More Instantly...
Stevanato Group S.p.A. Company Name:
STVN Stock Symbol:
NYSE Market:
Stevanato Group S.p.A. Website:
2024-07-04 19:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-24 21:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Cisterna’s site is the first to implement premium solutions outside the Group’s headquarters in Piombino Dese to meet the growing demand for biopharmaceuticals, such as GLP-1s in Europe. Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containme...